137 related articles for article (PubMed ID: 29321391)
1. [Prothymosinα, as a neuroprotective DAMPs/Alarmins molecule].
Ueda H; Maeda S
Nihon Yakurigaku Zasshi; 2018; 151(1):15-19. PubMed ID: 29321391
[TBL] [Abstract][Full Text] [Related]
2. Involvement of SNARE Protein Interaction for Non-classical Release of DAMPs/Alarmins Proteins, Prothymosin Alpha and S100A13.
Matsunaga H; Halder SK; Ueda H
Cell Mol Neurobiol; 2021 Nov; 41(8):1817-1828. PubMed ID: 32856232
[TBL] [Abstract][Full Text] [Related]
3. Prothymosin alpha and cell death mode switch, a novel target for the prevention of cerebral ischemia-induced damage.
Ueda H
Pharmacol Ther; 2009 Sep; 123(3):323-33. PubMed ID: 19500618
[TBL] [Abstract][Full Text] [Related]
4. Prothymosin alpha as robustness molecule against ischemic stress to brain and retina.
Ueda H; Matsunaga H; Uchida H; Ueda M
Ann N Y Acad Sci; 2010 Apr; 1194():20-6. PubMed ID: 20536446
[TBL] [Abstract][Full Text] [Related]
5. Stress-induced non-vesicular release of prothymosin-α initiated by an interaction with S100A13, and its blockade by caspase-3 cleavage.
Matsunaga H; Ueda H
Cell Death Differ; 2010 Nov; 17(11):1760-72. PubMed ID: 20467443
[TBL] [Abstract][Full Text] [Related]
6. Prothymosin alpha and its mimetic hexapeptide improve delayed tissue plasminogen activator-induced brain damage following cerebral ischemia.
Halder SK; Matsunaga H; Ueda H
J Neurochem; 2020 Jun; 153(6):772-789. PubMed ID: 31454420
[TBL] [Abstract][Full Text] [Related]
7. Prothymosin alpha plays a key role in cell death mode-switch, a new concept for neuroprotective mechanisms in stroke.
Ueda H
Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):315-23. PubMed ID: 18176798
[TBL] [Abstract][Full Text] [Related]
8. Prothymosin-alpha plays a defensive role in retinal ischemia through necrosis and apoptosis inhibition.
Fujita R; Ueda M; Fujiwara K; Ueda H
Cell Death Differ; 2009 Feb; 16(2):349-58. PubMed ID: 18989338
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective impact of prothymosin alpha-derived hexapeptide against retinal ischemia-reperfusion.
Ueda H; Halder SK; Matsunaga H; Sasaki K; Maeda S
Neuroscience; 2016 Mar; 318():206-18. PubMed ID: 26779836
[TBL] [Abstract][Full Text] [Related]
10. Prothymosin-alpha preconditioning activates TLR4-TRIF signaling to induce protection of ischemic retina.
Halder SK; Matsunaga H; Ishii KJ; Ueda H
J Neurochem; 2015 Dec; 135(6):1161-77. PubMed ID: 26364961
[TBL] [Abstract][Full Text] [Related]
11. Prothymosin-α Variants Elicit Anti-HIV-1 Response via TLR4 Dependent and Independent Pathways.
Gusella GL; Teixeira A; Aberg J; Uversky VN; Mosoian A
PLoS One; 2016; 11(6):e0156486. PubMed ID: 27310139
[TBL] [Abstract][Full Text] [Related]
12. Non-Vesicular Release of Alarmin Prothymosin α Complex Associated with Annexin-2 Flop-Out.
Ueda H
Cells; 2023 Jun; 12(12):. PubMed ID: 37371039
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective DAMPs member prothymosin alpha has additional beneficial actions against cerebral ischemia-induced vascular damages.
Maeda S; Sasaki K; Halder SK; Fujita W; Ueda H
J Pharmacol Sci; 2016 Sep; 132(1):100-104. PubMed ID: 27543170
[TBL] [Abstract][Full Text] [Related]
14. Neuron-specific non-classical release of prothymosin alpha: a novel neuroprotective damage-associated molecular patterns.
Halder SK; Matsunaga H; Ueda H
J Neurochem; 2012 Oct; 123(2):262-75. PubMed ID: 22853710
[TBL] [Abstract][Full Text] [Related]
15. Prothymosin α plays multifunctional cell robustness roles in genomic, epigenetic, and nongenomic mechanisms.
Ueda H; Matsunaga H; Halder SK
Ann N Y Acad Sci; 2012 Oct; 1269():34-43. PubMed ID: 23045968
[TBL] [Abstract][Full Text] [Related]
16. [Lysophosphatidic Acid Receptor Signaling Underlying Chronic Pain and Neuroprotective Mechanisms through Prothymosin α].
Ueda H
Yakugaku Zasshi; 2019; 139(11):1403-1415. PubMed ID: 31685737
[TBL] [Abstract][Full Text] [Related]
17. Prothymosin Alpha: An Alarmin and More..
Samara P; Karachaliou CE; Ioannou K; Papaioannou NE; Voutsas IF; Zikos C; Pirmettis I; Papadopoulos M; Kalbacher H; Livaniou E; Tsitsilonis OE; Voelter W
Curr Med Chem; 2017; 24(17):1747-1760. PubMed ID: 28521686
[TBL] [Abstract][Full Text] [Related]
18. Evidence for ProTα-TLR4/MD-2 binding: molecular dynamics and gravimetric assay studies.
Omotuyi O; Matsunaga H; Ueda H
Expert Opin Biol Ther; 2015; 15 Suppl 1():S223-9. PubMed ID: 25604147
[TBL] [Abstract][Full Text] [Related]
19. Novel neuroprotective action of prothymosin α-derived peptide against retinal and brain ischemic damages.
Halder SK; Matsunaga H; Yamaguchi H; Ueda H
J Neurochem; 2013 Jun; 125(5):713-23. PubMed ID: 23278181
[TBL] [Abstract][Full Text] [Related]
20. Beneficial actions of prothymosin alpha-mimetic hexapeptide on central post-stroke pain, reduced social activity, learning-deficit and depression following cerebral ischemia in mice.
Sasaki K; Halder SK; Matsunaga H; Ueda H
Peptides; 2020 Apr; 126():170265. PubMed ID: 31982448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
